Research And Development
Biotechnology
Biopharmaceutical

BioCryst

$3.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.18%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, ETFs, and crypto commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. Read More The company was founded in 1986 and is headquartered in Durham, NC.

Employees
100
Headquarters
Durham, North Carolina
Founded
1986
Market Cap
373.82M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.19M
High Today
$3.41
Low Today
$3.29
Open Price
$3.39
Volume
871.77K
52 Week High
$9.95
52 Week Low
$2.80

Collections

Research And Development
Biotechnology
Biopharmaceutical
Pharmaceutical
Health
Technology
US
North America

BCRX Earnings

-$0.28
-$0.24
-$0.19
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.